Tag: ozempic

Could GLP-1 Receptor Agonists Help Prevent Infections in People with Diabetes? A Nationwide Study Says Yes—At Least for the Lungs and Feet #ActAgainstAmputation #DiabeticFoot #GLP1RA

A new nationwide study out of Taiwan adds fresh weight to the growing list of potential benefits offered by GLP-1 receptor agonists (GLP-1RAs)—a class of medications already known for their glycemic control, cardiovascular protection, and weight loss benefits. This time, the focus is on something more insidious: infections that land people in the hospital. In... Continue Reading →

0

Physicians Are Healing Themselves—A Reflection on @GinaKolata NYT Article and Our Colleague, Prof. John Buse

Screenshot In a recent New York Times article, Gina Kolata explores a striking trend in modern medicine: physicians, particularly in cardiology and endocrinology, are increasingly turning to GLP-1 receptor agonists like Ozempic, Wegovy, and Zepbound—not just for their patients, but for themselves. The piece highlights how these medications, initially designed to manage diabetes, are now being embraced by medical professionals... Continue Reading →

0

Beyond Glycemic Control: Exploring GLP-1 Agonists for Diabetic Foot Ulcer Healing

Introduction The battle against diabetic foot ulcers (DFUs) remains one of the most challenging aspects of diabetes care. With recent advances in diabetes medications, specifically GLP-1 receptor agonists (GLP-1 RAs), there is growing interest in how these drugs might support wound healing and improve DFU outcomes. Traditionally prescribed for glycemic control, GLP-1 RAs are showing... Continue Reading →

0

Up ↑

Verified by MonsterInsights